Altimmune Market Cap

Altimmune has a market cap or net worth of $437.17 million as of January 5, 2026. Its market cap has decreased by -31.70% in one year.

Market Cap

437.17M

Enterprise Value

188.26M

1-Year Change

-31.70%

Ranking

#3255

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $437.17M, an increase of 436.40%. That is a compound annual growth rate of 8.65%.

Market Cap History

Date	Market Cap	% Change
Jan 2, 2026	365.90M	-2.79%
Dec 31, 2025	376.40M	-26.60%
Dec 31, 2024	512.80M	-15.16%
Dec 29, 2023	604.40M	-25.26%
Dec 30, 2022	808.70M	122.17%
Dec 31, 2021	364.00M	-2.41%
Dec 31, 2020	373.00M	1,186.21%
Dec 31, 2019	29.00M	61.11%
Dec 31, 2018	18.00M	-42.12%
Dec 29, 2017	31.10M	-85.66%
Dec 30, 2016	216.90M	77.06%
Dec 31, 2015	122.50M	6.80%
Dec 31, 2014	114.70M	17.88%
Dec 31, 2013	97.30M	79.52%
Dec 31, 2012	54.20M	-11.58%
Dec 30, 2011	61.30M	-64.57%
Dec 31, 2010	173.00M	210.59%
Dec 31, 2009	55.70M	-6.39%
Dec 31, 2008	59.50M	-31.77%
Dec 31, 2007	87.20M	1.04%
Dec 29, 2006	86.30M	4.10%
Dec 30, 2005	82.90M	1.72%
Oct 6, 2005	81.50M	-

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	962.51B
Johnson & Johnson	496.77B
AbbVie	405.49B
UnitedHealth Group	305.74B
AstraZeneca	287.81B
Novartis AG	266.00B
Merck & Co.	264.21B
Novo Nordisk	230.76B

Market Cap Rankings